Even though pharmacological industries have produced a number of new antibiotics in the
last three decades, resistance to these drugs by microorganisms has increased.
Approximately, 20% of the plants found in the world have been submitted to pharmaceutical
or biological test and a sustainable number of new antibiotics introduced in the market
are obtained from natural or semisynthetic resources. It has been reported that between
the years 1983 and 1994 (Cragg et al., 1999), the systematic screening of antibacterial
plant extracts represents a continuous effort to find new compounds with the potential to
act against multiresistant bacteria. According to World Health Organization (Santos et al.,
1995), medicinal plants would be the best source to obtain a variety of drugs. In general,
bacteria have the genetic ability to transmit and acquire resistance to drugs, which are
utilized as therapeutic agents (Cohen, 1992). Such a fact is a cause for concern, because
of the number of patients in hospitals who have suppressed immunity and due to new
bacterial strains which are multiresistant.
The problem of microbial resistance is growing, and the outlook for the use of
antimicrobial drugs in the future is still uncertain. Therefore, actions must be taken to reduce
this problem, for example, to control the use of antibiotic, perform research to better understand the genetic mechanisms of resistance, and continue studies to develop new drugs,
either synthetic or natural. The ultimate goal is to offer appropriate and efficient
antimicrobial drugs to the patient.
For a long period of time, plants have been a valuable source of natural products for
maintaining human health, especially in the last decade with more intensive studies for
natural therapies.
|